Asterias Biotherapeutics, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 29, 2016

Attached files

file filename
EX-31 - EXHIBIT 31 - Asterias Biotherapeutics, Inc.ex31.htm
EX-23.2 - EXHIBIT 23.2 - Asterias Biotherapeutics, Inc.ex23_2.htm
EX-10.31 - EXHIBIT 10.31 - Asterias Biotherapeutics, Inc.ex10_31.htm
EX-10.33 - EXHIBIT 10.33 - Asterias Biotherapeutics, Inc.ex10_33.htm
EX-10.35 - EXHIBIT 10.35 - Asterias Biotherapeutics, Inc.ex10_35.htm
EX-10.34 - EXHIBIT 10.34 - Asterias Biotherapeutics, Inc.ex10_34.htm
EX-10.32 - EXHIBIT 10.32 - Asterias Biotherapeutics, Inc.ex10_32.htm
10-K - ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2015 - Asterias Biotherapeutics, Inc.form10k.htm
EX-32 - EXHIBIT 32 - Asterias Biotherapeutics, Inc.ex32.htm
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-200745 and 333-204441), and on Form S-8 (Registration No. 333-202674 and 333-206237) and related prospectuses of Asterias Biotherapeutics, Inc. of our reports dated March 29, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting of Asterias Biotherapeutics, Inc., which appear in this Annual Report on Form 10-K.

/s/ OUM & CO. LLP

San Francisco, California
March 29, 2016
 
 

Asterias Biotherapeutics, Inc. Reports